| Original document(46 pages) 中文版 |
The invention relates to compounds having formula (I), the preparation method thereof and the use of same in therapeutics, wherein: R1 represents a (C1-C6)alkyl, a (C3-C7)cycloalkyl which is unsubstituted or is mono- or poly-substituted, a (C3-C7)cycloalkylmethyl which is unsubstituted or is mono- or poly-substituted, a phenyl which is unsubstituted or substituted; a benzyl which is unsubstituted or is mono- or disubstituted, a thienyl which is unsubstituted or substituted; R2 represents a hydrogen atom or a (C1-C3)alkyl; R3 represents a hydrogen atom or a (C1-C5)alkyl; R4, R5, R6, R7, R8 and R9 each represent, independently of each other, a hydrogen atom, a halogen atom, a (C1-C7)alkyl, a (C1-C5)alkoxy, a trifluoromethyl radical or a S(O)nAlk group; n represents 0, 1 or 2; and Alk represents a (C1-C4)alkyl. The invention also relates to the preparation method thereof and to the use of same in therapeutics. |
Application Number
申请号 |
200580002229 |
Application Date
申请日 |
2005.01.07 |
| Title 名称 |
Derivatives of N'- (1,5-diphenyl-1H-pyrazol-3-yl) sulphonamide with CBI receptor affinity |
Publication Number
公开号 |
1910157 |
Publication Date
公开日 |
2007.02.07 |
| Approval Pub. Date |
|
Granted Pub. Date |
|
| International Classification 分类号 |
C07D231/12;A61K31/415;A61P25/00;C07D409/12;C07D413/14 |
Applicant(s) Name
申请人 |
Sanofi Aventis |
| Address 地址 |
|
| Inventor(s) Name 发明人 |
Barth Francis;Congy Christian;Martinez Serge;Rinaldi-carmona Murielle |
| Attorney & Agent 代理人 |
liu weisheng lin sen |
| More information 更 多 信 息 |
|
| Related patents information |
|
|
|
|
|
|